# Fluent, Inc.: overview

FLNT · Nasdaq · CIK 1460329 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/flnt.md) · [Financials](/companies/flnt/financials.md) · [Filings](/companies/flnt/filings.md) · [Insiders](/companies/flnt/insiders.md)

Latest reported revenue: [$48.4m](/filings/0001437749-26-027702.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-027702).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [64.5](/filings/0001437749-25-035012.md) | [65.4 d](/filings/0001437749-26-010679.md) | [55.2](/filings/0001437749-26-016747.md) | [44.7](/filings/0001437749-26-027702.md) | [47.0](/filings/0001437749-25-035012.md) | [61.8 d](/filings/0001437749-26-010679.md) | [44.9](/filings/0001437749-26-016747.md) | [48.4](/filings/0001437749-26-027702.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(6.0%)](/filings/0001437749-25-035012.md) | [(8.3%) d](/filings/0001437749-26-010679.md) | [(12.8%)](/filings/0001437749-26-016747.md) | [(15.9%)](/filings/0001437749-26-027702.md) | [(13.4%)](/filings/0001437749-25-035012.md) | [0.3% d](/filings/0001437749-26-010679.md) | [(8.7%)](/filings/0001437749-26-016747.md) | [(10.2%)](/filings/0001437749-26-027702.md) |
| Net margin | % | [(12.3%)](/filings/0001437749-25-035012.md) | [(5.2%) d](/filings/0001437749-26-010679.md) | [(15.0%)](/filings/0001437749-26-016747.md) | [(16.2%)](/filings/0001437749-26-027702.md) | [(16.1%)](/filings/0001437749-25-035012.md) | [(6.7%) d](/filings/0001437749-26-010679.md) | [(11.9%)](/filings/0001437749-26-016747.md) | [(12.7%)](/filings/0001437749-26-027702.md) |
| Diluted EPS | $ per share | [(0.48)](/filings/0001437749-25-035012.md) | not reported | [(0.39)](/filings/0001437749-26-016747.md) | [(0.30)](/filings/0001437749-26-027702.md) | [(0.27)](/filings/0001437749-25-035012.md) | not reported | [(0.17)](/filings/0001437749-26-016747.md) | [(0.20)](/filings/0001437749-26-027702.md) |
| Free cash flow | $m | [1.2 d](/filings/0001437749-25-035012.md) | [(2.2) d](/filings/0001437749-26-010679.md) | [2.1](/filings/0001437749-26-016747.md) | [0.9 d](/filings/0001437749-26-027702.md) | [(7.3) d](/filings/0001437749-25-035012.md) | [2.8 d](/filings/0001437749-26-010679.md) | [5.1](/filings/0001437749-26-016747.md) | [(4.8) d](/filings/0001437749-26-027702.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [329](/filings/0001437749-23-006714.md) | [361](/filings/0001437749-24-010639.md) | [298](/filings/0001437749-25-010194.md) | [255](/filings/0001437749-26-010679.md) | [209](/filings/0001437749-26-010679.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(1.4%)](/filings/0001437749-23-006714.md) | [(33.1%)](/filings/0001437749-24-010639.md) | [(20.2%)](/filings/0001437749-25-010194.md) | [(9.3%)](/filings/0001437749-26-010679.md) | [(9.7%)](/filings/0001437749-26-010679.md) |
| Net margin | % | [(3.1%)](/filings/0001437749-23-006714.md) | [(34.2%)](/filings/0001437749-24-010639.md) | [(21.2%)](/filings/0001437749-25-010194.md) | [(11.5%)](/filings/0001437749-26-010679.md) | [(13.0%)](/filings/0001437749-26-010679.md) |
| Diluted EPS | $ per share | [(0.13)](/filings/0001437749-23-006714.md) | [(1.51)](/filings/0001437749-24-010639.md) | [(4.59)](/filings/0001437749-25-010194.md) | [(1.80)](/filings/0001437749-26-010679.md) | [(1.05)](/filings/0001437749-26-010679.md) |
| Free cash flow | $m | [12.4](/filings/0001437749-23-006714.md) | [1.9](/filings/0001437749-24-010639.md) | [8.1](/filings/0001437749-25-010194.md) | [(14.1)](/filings/0001437749-26-010679.md) | [(1.5)](/filings/0001437749-26-010679.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/flnt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Bleichroeder LP](/funds/1781002.md) | 2026-06-30 | $4.3m | 1,142,857 |  | Reduced −285,714 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.9m | 519,909 |  | Added +152,292 |
| [Mink Brook Asset Management LLC](/funds/2052205.md) | 2026-06-30 | $1.5m | 409,033 |  | Added +70,049 |
| [SEI INVESTMENTS CO](/funds/350894.md) | 2026-06-30 | $947.6k | 254,055 |  | Reduced −254,055 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $652.3k | 174,892 |  | Added +12,431 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $648.0k | 173,637 |  | Reduced −7,347 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $354.5k | 95,040 |  | Added +647 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $258.7k | 69,350 |  | Unchanged |
| [Bleakley Financial Group, LLC](/funds/1936953.md) | 2026-06-30 | $249.7k | 66,955 |  | New +66,955 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $198.5k | 53,214 |  | Unchanged |

## Recent filings

[All 1,069 filings](/companies/flnt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 20:30 ET | [8-K](/filings/0001437749-26-032037.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001437749-26-032037 |
| 2026-08-13 | 20:31 ET | [10-Q](/filings/0001437749-26-027702.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027702 |
| 2026-08-10 | 20:18 ET | [8-K](/filings/0001437749-26-026782.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026782 |
| 2026-06-22 | 10:05 ET | [8-K](/filings/0001437749-26-021214.md) | 7.01 Regulation FD disclosure | 0001437749-26-021214 |
| 2026-06-18 | 00:05 ET | [8-K](/filings/0001437749-26-021019.md) | 5.07 Shareholder vote results | 0001437749-26-021019 |
| 2026-05-13 | 20:31 ET | [10-Q](/filings/0001437749-26-016747.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016747 |
| 2026-05-13 | 20:18 ET | [8-K](/filings/0001437749-26-016736.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016736 |
| 2026-05-07 | 13:34 ET | [DEF 14A](/filings/0001437749-26-015328.md) | Proxy statement, period 2025-12-31 | 0001437749-26-015328 |
| 2026-05-06 | 10:00 ET | [DEF 14A](/filings/0001437749-26-014994.md) | Proxy statement, period 2026-06-17 | 0001437749-26-014994 |
| 2026-04-30 | 21:16 ET | [10-K/A](/filings/0001437749-26-014268.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-014268 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-010679.md), filed Mar 31, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b88907ac-3878-4ac2-8fcf-abdef94f4577)

## About the filer

- CIK: 1460329
- Tickers: FLNT
- Exchange: Nasdaq
- SIC code: 7310 Services-Advertising
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.
